Several other biomarkers such as carcinoembryonic antigen (CEA) and carbohydrate antigen 242 (CA242) were identified as biomarkers for the diagnosis, prognosis and surveillance of PC. The gene discussed is CEACAM5; the disease is pachyonychia congenita.